Financial & Business, Supplier News

Vance Street Acquires Injectech, Forms Medical Molding Platform

Acquiring Injectech grows VSC Medical Molding’s single-use fluid management solutions for the medical device, life science, and bioprocessing markets.

Author Image

By: Sam Brusco

Associate Editor

Private equity firm Vance Street Capital (VSC) has acquired Injectech from The West Group and formed the VSC Medical Molding platform.

Established in 1998, Injectech specializes in injection molding and cleanroom assembly and is an engineering partner to medical device OEMs. The Fort Collins, Colorado-based company develops polymer-based fluid management components, including male and female luers, tube-to-tube connectors, check valves, spikes, and custom assemblies used in the medical device, life science, and bioprocessing industries.

“Injectech has always focused on solving complex fluid management challenges through precision engineering and responsive manufacturing,” said Injectech CEO Jeff Wicks. “Partnering with Vance Street enables us to expand our technical resources, increase scalability, and continue investing in advanced molding technologies, automation, and material innovation.”

Acquiring Injectech grows VSC Medical Molding’s single-use fluid management solutions for the medical device, life science, and bioprocessing markets. In addition to Injectech, the VSC Medical Molding Platform is composed of Plastic Design Company (acquired in 2021) and Resenex (acquired in 2024).

Injectech is Vance Street’s third acquisition in the medical and life science manufacturing sector this year, in addition to Zenith Adhesive Component (ZAC) and MRPC.

“We are delighted to welcome Injectech to the VSC Medical Molding family,” said Jeff Kyle, CEO of VSC Medical Molding. “By combining VSC Medical Molding’s precision molding and in-house tooling capabilities with Injectech’s extensive component portfolio of custom and standard fluid management solutions, we are expanding our ability to deliver specialized solutions for our customers across critical medical, life science and bioprocessing applications.”

VSC Medical Molding’s fluid management division is now comprised of Injectech and Resenex. The platform aims to meet a wider range of fluid management needs through a broader product and component portfolio, as well as expanded custom component capabilities.

“We are excited about the next chapter of growth and our partnership with VSC Medical Molding and Vance Street,” said Jeff Wicks, CEO of Injectech.  “This combination will accelerate Injectech’s growth and product innovation, further enhancing our ability to meet the evolving needs of our customers.”

“Injectech strengthens our VSC Medical Molding platform with deep expertise in precision fluid management and a culture of innovation,” added Steve Sandbo, partner at Vance Street Capital. “Together, we will continue building a leading precision molding and fluid management platform serving the medical device, life science and bioprocessing industries.”

Vance Street’s other partners in assembling a comprehensive manufacturing and engineered-component ecosystem include:

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics